Information
for Use
Cutting-Edge Precision: Explore the Technical Details Behind Ophtascan's Innovation.
/00 – 1
The Ophtascan™ system is a medical screening technology designed to screen for cancer and/or type-2 diabetes in human patients. The Ophtascan™ system consists of proprietary hardware named OncoLenz™ and an artificial intelligence enabled software also named Ophtascan application. The hardware, OncoLenz™ enables obtaining stable, accurate and clear photo of the patient’s eyes using a specific mobile device and the software analyzes the eyes for deviations in the iris’, pupil’s and sclera’s patterns and colors compared to the average healthy eye’s structure. The identified specific deviated patterns indicate abnormalities in the cell structures and blood vessels and thereby evidencing the risk of cancer and/or type-2 diabetes in the body.
/00 – 1
Oncollect™ is a research data collection system used solely to collect eye images from human participants for scientific research purposes. It uses proprietary hardware called Oncolenz™ to capture stable and high-quality photographs of the iris and sclera using a specified mobile device. The collected data is securely stored and used only for research and model development. Oncollect™ does not perform medical screening, diagnosis, or provide clinical decision.
/00 – 1
The Oncolenz headset is an innovative medical accessory designed to enhance the process of capturing high-quality images of the iris using a smartphone. Developed with precision and user comfort in mind, the OncoLenz headset offers a unique solution for healthcare professionals.
/00 – 3
Ergonomic Design: The Oncolenz headset is ergonomically designed to fit comfortably on the patient’s head. The adjustable straps ensure a secure fit, accommodating various head sizes while maintaining stability during the imaging process.
Smartphone Holder: The headset includes a specially designed holder compatible with the Samsung Galaxy A34 smartphone. This holder ensures the smartphone is securely positioned, minimizing movement and enhancing the accuracy of the images captured.
Eyelid Retractor Module: The headset includes an integrated eyelid retractor module that gently assists in opening and keeping the eyes open during imaging. This ensures a fully visible iris, minimizes the need for manual intervention, and increases image quality and consistency.
Imaging Tube: The headset features a specially coated imaging tube that minimizes internal reflections during photography. This coating enhances contrast and clarity, contributing to consistently high-quality iris images.
Adjustable Lens Positioning: The OncoLenz headset allows for fine adjustments of the smartphone’s camera lens position, ensuring optimal alignment with the patient’s eye. This adjustability is crucial for obtaining high-quality, focused images.
Compatibility with Ophtascan Software: The headset is designed to be used in conjunction with the Ophtascan software, which provides advanced image processing and diagnostic capabilities. This combination ensures a seamless workflow from image capture to analysis.
/00 – 4
| Specifications | Details |
|---|---|
| Application | Eye Photography, Cancer Screening |
| Frame Color | White |
| Phone Case Color | Black |
| Imaging Tube Color | Black |
| Head Strap Color | Black |
| Device Size | 16 cm / 13 cm / 7.5 cm |
| Device Weight | 300g |
| Model | Oncolenz V3.0 |
| Occupation | Health Professionals |
| Patient | Adult |
Frequent Asked Questions
Ophtascan’s AI algorithm has a precision rate of over +95%, making it one of the most reliable cancer screening tools available.
Yes, Ophtascan’s Algorithm is Designed to Screen for Various Types of Cancer Such as Breast, Lungs, Uterine, Cervical and Prostate by Analyzing Distinct Patterns in the Eyes.
Yes, Ophtascan is the first cancer screening system of its kind to be clinically tested and validated, ensuring its reliability and effectiveness in real-world settings. It has been certified by the European Commison as a CE Class 1 Medical Device.
Affordable Excellence
Delivering top-tier cancer screening at an accessible cost for everyone.